Form 4: Johnson & Johnson Director Eugene A. Woods Reports Acquisition of Deferred Share Units

Director Eugene A. Woods reported the acquisition of deferred share units in Johnson & Johnson, to be settled in cash upon termination of directorship.

Summary

• Eugene A. Woods, a director of Johnson & Johnson, filed a Form 4 to report changes in beneficial ownership.
• On April 25, 2024, Woods acquired 1,385.697 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• These DSUs will be settled in cash upon termination of Woods' directorship, with each DSU representing the fair market value of one share of Common Stock on the settlement date.
• Woods also holds 2,139.143 DSUs, which include dividend equivalent rights accrued from the Issuer's quarterly dividend.
• The reported transaction did not involve any purchase or sale of common stock directly.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (acquisition of deferred share units) by a company director, indicating a neutral to slightly positive sentiment as it aligns director interests with company performance.

Positives

• The acquisition of DSUs reflects a continued alignment of the director's interests with the long-term performance of the company.
• The Deferred Fee Plan for Directors allows for deferred compensation, potentially offering tax advantages.

Future Outlook

The DSUs will be settled in cash upon the termination of Woods' directorship, reflecting the value of Johnson & Johnson's common stock at that time.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Comparison to Industry Standards

• Deferred compensation plans for directors are common among large, publicly traded companies like Johnson & Johnson.
• Companies such as Pfizer (PFE) and Merck (MRK) also utilize similar deferred compensation structures for their board members to align their interests with shareholder value.

Stakeholder Impact

• The acquisition of DSUs aligns the director's interests with those of shareholders, as the value of the DSUs is tied to the performance of Johnson & Johnson's common stock.

Key Dates